QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
NASDAQ:SHPH

Shuttle Pharmaceuticals (SHPH) Stock Price, News & Analysis

$0.40
+0.02 (+5.26%)
(As of 03/4/2024 ET)
Today's Range
$0.39
$0.40
50-Day Range
$0.36
$0.58
52-Week Range
$0.35
$2.75
Volume
26,817 shs
Average Volume
177,531 shs
Market Capitalization
$6.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Shuttle Pharmaceuticals MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of Shuttle Pharmaceuticals in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1,912 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.69 out of 5 stars


SHPH stock logo

About Shuttle Pharmaceuticals Stock (NASDAQ:SHPH)

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.

SHPH Stock Price History

SHPH Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Shuttle Pharmaceuticals reports Q3 results
Shuttle Pharmaceuticals (NASDAQ: SHPH)
See More Headlines
Receive SHPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/04/2024
Next Earnings (Estimated)
3/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SHPH
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-3,030,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.56 per share

Miscellaneous

Free Float
9,503,000
Market Cap
$6.24 million
Optionable
Not Optionable
Beta
-1.17
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Anatoly Dritschilo M.D. (Age 80)
    Co-Founder, MD, CEO & Chairman of the Board
    Comp: $91.42k
  • Mr. Peter Dale Dritschilo M.B.A. (Age 55)
    M.D., President & COO
    Comp: $94.29k
  • Mr. Michael P. Vander Hoek (Age 64)
    CFO and VP of Operations & Regulatory
    Comp: $79.48k
  • Dr. Tyvin A. Rich M.D. (Age 76)
    Chief Medical Officer
    Comp: $65.06k
  • Dr. Milton Brown CSC (Age 59)
    M.D., Ph.D., Co-Founder & Director
  • Dr. Mira Jung Ph.D. (Age 75)
    Co-Founder & Chief Scientific Officer for Biology
  • Mr. Gene Jung Esq.
    General Counsel














SHPH Stock Analysis - Frequently Asked Questions

How have SHPH shares performed in 2024?

Shuttle Pharmaceuticals' stock was trading at $0.4550 at the start of the year. Since then, SHPH stock has decreased by 12.1% and is now trading at $0.40.
View the best growth stocks for 2024 here
.

Are investors shorting Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals saw a drop in short interest during the month of February. As of February 15th, there was short interest totaling 87,700 shares, a drop of 35.3% from the January 31st total of 135,500 shares. Based on an average trading volume of 157,500 shares, the short-interest ratio is presently 0.6 days. Currently, 1.0% of the shares of the stock are short sold.
View Shuttle Pharmaceuticals' Short Interest
.

When is Shuttle Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 20th 2024.
View our SHPH earnings forecast
.

When did Shuttle Pharmaceuticals IPO?

(SHPH) raised $10 million in an IPO on Wednesday, August 31st 2022. The company issued 1,225,888 shares at $8.13 per share.

How do I buy shares of Shuttle Pharmaceuticals?

Shares of SHPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SHPH) was last updated on 3/4/2024 by MarketBeat.com Staff